SCHEMBL86769

SCHEMBL86769

CCOC(=O)C(C)(CC(=O)c1ccc(OC)c(C(F)(F)F)c1)C(=O)OCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
THRA P10827 1/20 0.42
THRB P10828 1/20 0.42
POLB P06746 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
STING1 Q86WV6 1/20 0.41
TSHR P16473 2/20 0.39
HSD17B2 P37059 1/20 0.39
CTNNB1 P35222 1/20 0.39
WNT3A P56704 1/20 0.39
MAPT P10636 1/20 0.39
GPBAR1 Q8TDU6 1/20 0.39
RARA P10276 1/20 0.39
RARB P10826 1/20 0.39
RARG P13631 1/20 0.39
BRAF P15056 1/20 0.39
S1PR1 P21453 2/20 0.38
CYP2C19 P33261 1/20 0.38
CNR2 P34972 1/20 0.38
SIRT1 Q96EB6 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL80165 0.85 ALDH1A1 (0.45) ALDH1A1THRATHRBPOLBNPSR1
SCHEMBL2463688 0.83 ALDH1A1 (0.44) ALDH1A1THRATHRBPOLBNPSR1
SCHEMBL14776123 0.80 HSD17B2 (0.60) ALDH1A1POLBTSHRHSD17B2MAPT
SCHEMBL86406 0.78 S1PR1 (0.43) MAPTS1PR1CNR2S1PR5
SCHEMBL81878 0.76 GSK3B (0.50) ALDH1A1THRATHRBTSHRCTNNB1
SCHEMBL12336977 0.76 THRA (0.45) ALDH1A1THRATHRBTSHRCTNNB1
SCHEMBL21176907 0.76 THRA (0.46) ALDH1A1THRATHRBTSHRCTNNB1
SCHEMBL29638911 0.76 THRA (0.46) ALDH1A1THRATHRBTSHRCTNNB1
SCHEMBL16140749 0.75 THRA (0.41) THRATHRBTSHRCTNNB1WNT3A
SCHEMBL80164 0.74 THRA (0.41) ALDH1A1THRATHRBTSHRGPBAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129361-B2 Amine compound and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-03-06 US disclosed
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF HLA-B, HLA-A, HLA-C ALDH1A1 646/4885THRA 1980/4885THRB 1455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.